Frankfurt - Delayed Quote EUR

Phibro Animal Health Corporation (PB8.F)

21.20
-0.40
(-1.85%)
At close: June 2 at 8:01:28 AM GMT+2
Loading Chart for PB8.F
  • Previous Close 21.60
  • Open 21.20
  • Bid --
  • Ask --
  • Day's Range 21.20 - 21.20
  • 52 Week Range 14.20 - 25.40
  • Volume 50
  • Avg. Volume 0
  • Market Cap (intraday) 853.58M
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) 31.18
  • EPS (TTM) 0.68
  • Earnings Date Aug 26, 2025 - Sep 1, 2025
  • Forward Dividend & Yield 0.42 (1.96%)
  • Ex-Dividend Date Jun 4, 2025
  • 1y Target Est --

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

www.pahc.com

1,940

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PB8.F

View More

Performance Overview: PB8.F

Trailing total returns as of 6/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PB8.F
6.55%
S&P 500 (^GSPC)
0.92%

1-Year Return

PB8.F
34.09%
S&P 500 (^GSPC)
12.48%

3-Year Return

PB8.F
34.42%
S&P 500 (^GSPC)
42.12%

5-Year Return

PB8.F
6.53%
S&P 500 (^GSPC)
92.67%

Compare To: PB8.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PB8.F

View More

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    869.69M

  • Enterprise Value

    1.48B

  • Trailing P/E

    31.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    3.74

  • Enterprise Value/Revenue

    1.42

  • Enterprise Value/EBITDA

    13.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.67%

  • Return on Assets (ttm)

    6.26%

  • Return on Equity (ttm)

    11.86%

  • Revenue (ttm)

    1.19B

  • Net Income Avi to Common (ttm)

    31.79M

  • Diluted EPS (ttm)

    0.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    75.05M

  • Total Debt/Equity (mrq)

    289.49%

  • Levered Free Cash Flow (ttm)

    -67.58M

Research Analysis: PB8.F

View More

Company Insights: PB8.F

Research Reports: PB8.F

View More

People Also Watch